GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Cartica Acquisition Corp (NAS:CITE) » Definitions » Sloan Ratio %

Cartica Acquisition (Cartica Acquisition) Sloan Ratio % : 0.00% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cartica Acquisition Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Cartica Acquisition's Sloan Ratio for the quarter that ended in Mar. 2024 was 0.00%.

Warning Sign:

When sloan ratio (-416.38)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Mar. 2024, Cartica Acquisition has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Cartica Acquisition Sloan Ratio % Historical Data

The historical data trend for Cartica Acquisition's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cartica Acquisition Sloan Ratio % Chart

Cartica Acquisition Annual Data
Trend Dec21 Dec22 Dec23
Sloan Ratio %
- 104.39 -416.38

Cartica Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cartica Acquisition's Sloan Ratio %

For the Shell Companies subindustry, Cartica Acquisition's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cartica Acquisition's Sloan Ratio % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Cartica Acquisition's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Cartica Acquisition's Sloan Ratio % falls into.



Cartica Acquisition Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Cartica Acquisition's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(6.38--1.323
-200.918)/46.403
=-416.38%

Cartica Acquisition's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(0.413--1.349
-0)/47.038
=3.75%

Cartica Acquisition's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 3.021 (Jun. 2023 ) + 0.767 (Sep. 2023 ) + 0.527 (Dec. 2023 ) + -3.902 (Mar. 2024 ) = $0.41 Mil.
Cartica Acquisition's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was -0.56 (Jun. 2023 ) + -0.29 (Sep. 2023 ) + -0.163 (Dec. 2023 ) + -0.336 (Mar. 2024 ) = $-1.35 Mil.
Cartica Acquisition's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) + 0 (Mar. 2024 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cartica Acquisition  (NAS:CITE) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Cartica Acquisition has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Cartica Acquisition Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Cartica Acquisition's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cartica Acquisition (Cartica Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
1775 I Street NW, Suite 900, Washington, DC, USA, 20006
Cartica Acquisition Corp is a blank check company.
Executives
John F Levy director C/O WASHINGTON PRIME GROUP INC., 180 EAST BROAD STREET, COLUMBUS OH 43215
Kishore Kondragunta director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Suresh Guduru director, 10 percent owner, officer: Chief Executive Officer 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Kyle I. Parent director 3524 SILVERSIDE ROAD, SUITE 35B3524, WILMINGTON DE 19801
Rana Gujral director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Suresh Singamsetty director 3524 SILVERSIDE ROAD, SUITE 35B, WILMINGTON DE 19810
Asif Ramji director 3399 PEACHTREE ROAD NE, SUITE 1900, ATLANTA GA 30326
Parul Bhandari director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Cartica Acquisition Partners, Llc 10 percent owner 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Steven J. Quamme director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Farida Khambata director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Sanjeev Goel director, officer: Chief Executive Officer 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
C. Brian Coad officer: COO and CFO 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Keki M. Mistry director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Subramanian Ramadorai director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006